Search for: "SANOFI-AVENTIS V APOTEX"
Results 21 - 40
of 92
Sorted by Relevance
|
Sort by Date
21 Jan 2007, 10:48 am
IPBiz wonder how all the "patent reformers" pontificating about KSR v. [read post]
7 May 2020, 5:29 am
The AusKat won't be restrained fromlaunching to attack that wrinkle on thesheets.....In a long-awaited judgment that will affect applications in Australia for interlocutory injunctions to restrain launch of pharmaceutical products, as well as claims for compensation following wrongful exclusion of generic or biosimilar pharmaceuticals from the market, the Federal Court of Australia dismissed a claim made by the Commonwealth government for compensation from Sanofi (Commonwealth of… [read post]
26 Jul 2014, 9:14 pm
Methods of medical treatment came under scrutiny of the US Supreme Court in Mayo Collaborative Services v Prometheus Laboratories, Inc and the Australian High Court in Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd (see High Court Rules Methods of Medical Treatment Patent-Eligible). [read post]
2 Jul 2007, 2:51 pm
Apotex Ambien CR: Sanofi-Aventis v. [read post]
14 Nov 2007, 8:59 pm
Torpharm/Apotex Eloxatin: Sanofi-Aventis v. [read post]
6 May 2007, 9:06 pm
Ambien CR: Sanofi-Aventis v. [read post]
4 Dec 2013, 4:34 am
Apotex Pty Ltd v Sanofi-Aventis Australia Pty Ltd [2013] HCA 50 (4 December 2013)A panel of five judges of the High Court has decided, by a majority of 4-1, that methods of treating the human body by the administration of a therapeutic drug constitute patent-eligible subject matter in Australia. [read post]
6 Aug 2007, 8:38 pm
Mylan Eloxatin: Sanofi-Aventis v. [read post]
2 Apr 2007, 9:52 pm
Exela Pharmsci Ambien CR: Sanofi-Aventis v. [read post]
16 Dec 2008, 11:47 pm
Sanofi-Synthelabo v. [read post]
18 Feb 2011, 11:47 am
The defendants in both sets of actions were Sanofi Aventis and Sanofi-Synthelabo, Inc., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
19 Apr 2012, 10:00 pm
LLC v. [read post]
19 Apr 2012, 10:00 pm
LLC v. [read post]
21 Nov 2014, 4:00 am
Justice Gleason found Sanofi-Aventis 2007 was “dispositive” and it was an abuse for the brand to re-litigate obviousness in case2: “That issue was the same in both cases and arose directly from the patent, itself. [read post]
3 Oct 2007, 10:00 pm
The issue is not unique to the pharmaceutical industry, but the pressure is a little more acute because of the absolute monopoly in the product enjoyed by the innovator company just prior to the first generic launch.In some jurisdictions, most notably the UK, a line of authorities has sprung up which requires the generic company to either obtain a declaration of non-infringement or revoke the patent prior to launch.In the ongoing global Plavix litigation, the Australian Federal Court recently… [read post]
31 Aug 2010, 10:01 pm
Apotex Inc. et al (Docket Report) Lovenox (Enoxaparin) – US: DC District Court denies preliminary injunction in generic Lovenox case; Is the juice worth the squeeze for Sanofi to appeal? [read post]
23 Jun 2009, 9:46 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: Eloxatin (Oxaliplatin) – US: District Court New Jersey grants summary judgment of non-infringement in favour of Hospira, Teva and others concerning patent relating to Sanofi’s Eloxatin: Sanofi-Aventis v Sandoz (SmartBrief) (The IP Factor) (GenericsWeb) (Patents4Life) General Europe’s… [read post]
1 Dec 2009, 9:45 am
(patent infringement) 10/29: Aventis Pharma S.A. and Sanofi-Aventis US, LLC v. [read post]
26 May 2007, 11:26 pm
District Judge Sid ney Stein in Manhattan could make a decision any day.Spokesmen for Bristol-Myers, Sanofi and Apotex all declined to comment. [read post]
7 Aug 2010, 4:46 am
By Dennis Crouch Briefing continues in the en banc appeal of TheraSense (Abbott) v. [read post]
